PPARG and polycystic ovary syndrome: Moreover, the protein expression levels of PPARγ were found to be low in the PCOS group (compared with the Control group, P<0.001), whereas AS-IV increased its expression in a dose-dependent manner (compared with +AS-IV 20 mg/kg group, P<0.01 and P<0.001) (Figure 3C).